Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
13,009,538
-
Share change
-
-272,884
-
Total reported value
-
$94,192,553
-
Put/Call ratio
-
208%
-
Price per share
-
$7.24
-
Number of holders
-
88
-
Value change
-
-$1,417,825
-
Number of buys
-
39
-
Number of sells
-
35
Institutional Holders of INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) as of Q2 2018
As of 30 Jun 2018 INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) had 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,009,538 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, NORGES BANK, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, PANAGORA ASSET MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC, and BANK OF MONTREAL /CAN/.
This table shows 88 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.